New study tracks Real-World use of advanced heart pacemakers
NCT ID NCT07393009
First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times
Summary
This study will observe 1000 people who receive BIOTRONIK pacemakers for conditions like slow heartbeat or heart failure. The goal is to see how well the devices work in everyday medical practice, focusing on safety and performance over time. Researchers will track device-related side effects and how effectively the leads pace the heart.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- BIOTRONIK pacemaker devices (Solia CSP S pacing lead)
- What this could lead to
- If successful, this could confirm that these devices work well in everyday care, potentially improving pacing methods for heart rhythm problems.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients, and device risks like infection or lead issues remain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Feb 2033
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The patient population consists exclusively of patients with an indication for pacemaker or cardiac resynchronization therapy according to the current clinical practice.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Guideline indication for pacemaker or cardiac resynchronization therapy with or without defibrillation function (CRT-P/-D) * Patient is intended for a de novo implantation and LBBAP therapy with an investigational generator and an investigational lead OR has just been implanted with an investigational generator and an investigational lead positioned permanently deep within the intraventricular septum and has not yet been discharged from the hospital OR transitions from the BIO\|MASTER.CSP study * Ability to understand the nature of the study * Ability and willingness to perform all follow-up visits * Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIK Home Monitoring concept Exclusion Criteria: * Planned dation from intended use * Planned for cardiac surgical procedures, heart transplantation or interventional measures other than the study procedure within one year after enrollment * Life-expectancy less than 12 months * Pregnant or breast feeding * Age less than 18 years * Participation in an interventional clinical investigation, except for submodules within this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bradycardia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
40 sites in 13 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
A.O.U. Maggiore della Carita di Novara
RECRUITINGNovara, Italy
-
Assuta Medical Center
NOT_YET_RECRUITINGAshdod, Israel
-
Auckland City Hospital
NOT_YET_RECRUITINGGrafton, New Zealand
-
Central Hospital of Northern Pest - Military Hospital
RECRUITINGBudapest, Hungary
-
Centre Hospitalier Metz-Thionville
NOT_YET_RECRUITINGMetz, France
-
FN Kralovske Vinohrady
NOT_YET_RECRUITINGPrague, Czechia
-
Fakultní nemocnice Olomouc
NOT_YET_RECRUITINGOlomouc, Czechia
-
Fondazione Policlinico Universitario "Agostino Gemelli" Università Cattolica del Sacro Cuore
NOT_YET_RECRUITINGRoma, Italy
-
Herz- und Diabeteszentrum NRW
NOT_YET_RECRUITINGBad Oeynhausen, Germany
-
Hillel Yaffe Medical Center
NOT_YET_RECRUITINGHadera, Israel
-
Hospital La Luz
NOT_YET_RECRUITINGMadrid, Spain
-
Hospital Universitari Germans Trias i Pujol
NOT_YET_RECRUITINGBarcelona, Spain
-
Hospital Universitario 12 de Octubre
NOT_YET_RECRUITINGValencia, Spain
-
Hospital Universitario La Fe
NOT_YET_RECRUITINGValencia, Spain
-
Hôpital Gabriel Montpied
NOT_YET_RECRUITINGClermont-Ferrand, France
-
Hôpital Haut Lévêque
NOT_YET_RECRUITINGPessac, France
-
Hôpital de la Timone
NOT_YET_RECRUITINGMarseille, France
-
Hôpital privé du Confluent
NOT_YET_RECRUITINGNantes, France
-
Inselspital, Universitätsspital Bern
NOT_YET_RECRUITINGBern, Switzerland
-
Integral Healthcare
NOT_YET_RECRUITINGAdelaide, Australia
-
Kepler Universitätsklinikum GmbH
NOT_YET_RECRUITINGLinz, Austria
-
Kerckhoff-Klinik GmbH
NOT_YET_RECRUITINGBad Nauheim, Germany
-
Krankenhaus Porz am Rhein gGmbH
NOT_YET_RECRUITINGCologne, Germany
-
Niels-Stensen-Kliniken, Marienhospital Osnabrück
NOT_YET_RECRUITINGOsnabrück, Germany
-
Niguarda Hospital
NOT_YET_RECRUITINGMilan, Italy
-
Ospedale Di Summa - Perrino
NOT_YET_RECRUITINGBrindisi, Italy
-
Ospedale di Piove di Sacco
NOT_YET_RECRUITINGPiove di Sacco, Italy
-
Pauls Stradins Clinical University Hospital
NOT_YET_RECRUITINGRiga, Latvia
-
SS Annunziata Taranto
NOT_YET_RECRUITINGTaranto, Italy
-
Semmelweis University
NOT_YET_RECRUITINGBudapest, Hungary
-
Shaare Zedek MC
NOT_YET_RECRUITINGJerusalem, Israel
-
Soroka Medical Center
NOT_YET_RECRUITINGBeersheba, Israel
-
Tel Aviv Sourasky Medical Center
NOT_YET_RECRUITINGTel Aviv, Israel
-
Unidade Local de Saúde de Santa Maria, E. P. E.
NOT_YET_RECRUITINGLisbon, Portugal
-
Unidade local de Saúde de Coimbra, EPE - Centro Hospitalar Universitario de Coimbra
NOT_YET_RECRUITINGCoimbra, Portugal
-
Unidade local de Saúde de Sao José, EPE - Hospital Santa Marta
NOT_YET_RECRUITINGLisbon, Portugal
-
University of Pécs
RECRUITINGPécs, Hungary
-
University of Szeged
NOT_YET_RECRUITINGSzeged, Hungary
-
Universitäts-Herzzentrum Freiburg Bad Krozingen
NOT_YET_RECRUITINGBad Krozingen, Germany
-
Universitätsspital Zürich (USZ)
NOT_YET_RECRUITINGZurich, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaler boost heart pumping in COPD patients?
- Can zapping the heart beat drugs for AF in heart failure?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Why do some children arrive at the ER with a racing or skipping heart?
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?